Biodyne Income Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Operating Revenue	6,978	7,028	5,271
Other Revenue	-	-0	-
Revenue	6,978	7,028	5,271
Revenue Growth (YoY)	-	33.32%	-
Cost of Revenue	2,481	2,560	2,834
Gross Profit	4,497	4,468	2,438
Selling, General & Admin	2,088	2,404	3,027
Research & Development	242.85	272.16	251.76
Amortization of Goodwill & Intangibles	843.14	851.78	473.19
Other Operating Expenses	17.52	22.38	23.41
Operating Expenses	3,440	3,816	4,168
Operating Income	1,057	652.26	-1,730
Interest Expense	-0.16	-0.16	-0.17
Interest & Investment Income	461.37	547.96	587.38
Currency Exchange Gain (Loss)	-87.72	-459.92	705.35
Other Non Operating Income (Expenses)	-1.92	-6.58	-19.12
EBT Excluding Unusual Items	1,428	733.56	-456.37
Gain (Loss) on Sale of Investments	357.33	354.05	259.52
Gain (Loss) on Sale of Assets	16.2	20.8	55.75
Asset Writedown	-277	-277	-
Pretax Income	1,525	831.42	-141.1
Income Tax Expense	83.01	-20.18	-151.87
Net Income	1,442	851.59	10.77
Net Income to Common	1,442	851.59	10.77
Net Income Growth	-	7806.89%	-
Shares Outstanding (Basic)	30	29	-
Shares Outstanding (Diluted)	30	29	-
EPS (Basic)	48.72	28.89	-
EPS (Diluted)	48.72	28.89	-
Free Cash Flow	-3,299	-2,601	338.26
Free Cash Flow Per Share	-111.47	-88.24	-
Gross Margin	64.44%	63.57%	46.25%
Operating Margin	15.14%	9.28%	-32.81%
Profit Margin	20.66%	12.12%	0.20%
Free Cash Flow Margin	-47.28%	-37.01%	6.42%
EBITDA	2,298	1,980	-107.9
EBITDA Margin	32.93%	28.17%	-2.05%
D&A For EBITDA	1,241	1,328	1,622
EBIT	1,057	652.26	-1,730
EBIT Margin	15.14%	9.28%	-32.81%